Advertisement
Advertisement
PRGO
PERRIGO COMPANY PLC
16.04
USDSponsored
-0.90
-5.31%
Nov 19, 15:59 UTC -5
Closed
After-Market
16.14
+0.11
+0.65%
PERRIGO COMPANY PLC (PRGO) Earnings
PRGO Earnings Reports
Positive Surprise Ratio
PRGO beat 27 of 43 last estimates.
63%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
PERRIGO COMPANY PLC earnings per share and revenue
On Nov 04, 2026, PRGO reported earnings of 0.60 USD per share (EPS) for Q3 26, beating the estimate of 0.50 USD, resulting in a 18.44% surprise. Revenue reached 988.60 million, compared to an expected 1.01 billion, with a -1.82% difference. The market reacted with a +0.83% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%

Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
What were PERRIGO COMPANY PLC's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, PERRIGO COMPANY PLC reported EPS of $0.60, beating estimates by 18.44%, and revenue of $988.60M, -1.82% below expectations.
How did the market react to PERRIGO COMPANY PLC's Q3 2026 earnings?
The stock price moved up 0.83%, changed from $15.70 before the earnings release to $15.83 the day after.
When is PERRIGO COMPANY PLC expected to report next?
The next earning report is scheduled for --.
What are the forecasts for PERRIGO COMPANY PLC's next earnings report?
Based on --
analysts, PERRIGO COMPANY PLC is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.